U.S. Markets closed

RedHill Biopharma Ltd. (RDHL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.43+0.06 (+0.81%)
At close: 4:00PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts4134
Avg. Estimate-0.24-0.24-1.83-0.59
Low Estimate-0.39-0.24-1.89-1.25
High Estimate-0.05-0.24-1.77-0.11
Year Ago EPS-0.35-0.5-1.4-1.83
Revenue EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts4155
Avg. Estimate26.03M30M68.13M143.55M
Low Estimate23.63M30M64.9M114.21M
High Estimate29.7M30M72.6M172.6M
Year Ago Sales1.59M1.06M6.29M68.13M
Sales Growth (year/est)1,537.10%2,740.90%983.00%110.70%
Earnings History12/30/20193/30/20206/29/20209/29/2020
EPS Est.-0.24-0.24-0.07-0.16
EPS Actual-0.35-0.5-0.4-0.5
Difference-0.11-0.26-0.33-0.34
Surprise %-45.80%-108.30%-471.40%-212.50%
EPS TrendCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Current Estimate-0.24-0.24-1.83-0.59
7 Days Ago-0.24-0.24-1.83-0.59
30 Days Ago-0.24-0.24-1.42-0.59
60 Days Ago-0.14-0.01-0.98-0.34
90 Days Ago-0.080-0.66-0.2
EPS RevisionsCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRDHLIndustrySector(s)S&P 500
Current Qtr.31.40%N/AN/AN/A
Next Qtr.52.00%N/AN/AN/A
Current Year-30.70%N/AN/AN/A
Next Year67.80%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A